Blood Gas And Electrolyte Analyzer Market Size, Share, Trends, And Forecast, 2026-2033 Point-Of-Care Growth Drives Market To USD 4.3 Billion At 4.5% CAGR
Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Blood Gas And Electrolyte Analyzer Market Size, Share & Trends Analysis Report 2026-2033" has been added to ResearchAndMarkets.com's offering.
Blood Gas and Electrolyte Analyzer Market to Reach USD 4.3 Billion by 2033
The global blood gas and electrolyte analyzer market was valued at USD 3.0 billion in 2025 and is projected to increase from USD 3.2 billion in 2026 to USD 4.3 billion by 2033. According to the report, the market is expected to expand at a CAGR of 4.5% from 2026 to 2033. North America led the global market with a revenue share of 43.0% in 2025, supported by advanced healthcare infrastructure, strong adoption of diagnostic technologies, and sustained investment in critical care services.
Market growth is being driven by the rising prevalence of diabetes, cardiovascular diseases, chronic respiratory disorders, and kidney dysfunction. These conditions frequently require blood gas and electrolyte testing to support diagnosis, treatment planning, and continuous patient monitoring. Increasing disease incidence associated with lifestyle changes and urbanization is strengthening demand for accurate and rapid analysis across clinical laboratories, emergency departments, intensive care units, surgical environments, and point-of-care settings.
The expanding geriatric population is another major contributor to blood gas and electrolyte analyzer market growth. Older adults have a higher incidence of chronic and acute conditions that require close assessment of pH, oxygen, carbon dioxide, and electrolyte levels. Data released by the U.S. Census Bureau in June 2025 showed that the U.S. population aged 65 and older reached approximately 61.2 million in 2024, representing 18.0% of the total population. This figure increased from 59.3 million in 2023, indicating a continuing demographic shift that is expected to support analyzer adoption across hospitals, diagnostic centers, and other healthcare facilities.
Government funding, regulatory support, and healthcare infrastructure expansion are also improving market prospects. Regulatory standards focused on medical device accuracy, reliability, and safety are increasing confidence among healthcare providers. At the same time, investments in hospitals and clinics, including facilities in rural and remote areas, are creating demand for advanced diagnostic equipment. Training and awareness initiatives for healthcare professionals are further supporting the effective adoption of blood gas and electrolyte analyzers.
High acquisition and operating costs remain a significant market restraint. Advanced analyzers require substantial initial investment, while recurring expenses for reagents, cartridges, consumables, and maintenance increase the total cost of ownership. These financial requirements can limit adoption among healthcare providers in developing countries, particularly in parts of Southeast Asia where capital budgets remain constrained. Long-term purchasing decisions may therefore depend on cost efficiency, testing volume, reimbursement conditions, and available healthcare funding.
Market Segmentation
The report provides global, regional, and country-level revenue forecasts and analyzes industry trends and opportunities from 2021 to 2033. The market is segmented by product, end-use, and region.
- Product: Instruments and consumables Instrument type: Bench Top and portable systems Instrument brand: I-STAT, epoc, GEM Premier (3500& 5000), ABL Flex (90 and 800), Cobas, RAPID Series, and others End-use: Clinical Laboratory, point-of-care, Diagnostic Centers, and others
The regional analysis covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Country-level coverage includes the U.S., Canada, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Indonesia, Thailand, Vietnam, Philippines, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, and Kuwait.
Key Benefits of the Report
- Detailed market estimates and revenue forecasts across major products, end-use segments, regions, and countries Analysis of blood gas and electrolyte analyzer market trends, growth drivers, constraints, and emerging opportunities Competitive landscape insights covering the market presence and strategies of key participants Assessment of product innovation and developments shaping future diagnostic capabilities Actionable market intelligence to support investment planning, competitive positioning, and strategic decision-making
The report enables healthcare companies, medical device manufacturers, investors, and other stakeholders to evaluate growth opportunities, identify potential revenue streams, assess regional demand, and develop informed strategies for the evolving blood gas and electrolyte analyzer market.
Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. The internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product and end-use outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Blood Gas and Electrolyte Analyzer Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing prevalence of chronic diseases
3.2.1.2. Rising geriatric population
3.2.1.3. Increasing regulatory support and funding
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of advanced analyzers
3.2.2.2. Shortage of skilled professionals
3.3. Blood Gas and Electrolyte Analyzer Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Blood Gas and Electrolyte Analyzer Market: Product Estimates & Trend Analysis
4.1. Global Blood Gas and Electrolyte Analyzer Market: Product Dashboard
4.2. Global Blood Gas and Electrolyte Analyzer Market: Product Movement Analysis
4.3. Global Blood Gas and Electrolyte Analyzer Market by Product, Revenue
4.4. Instruments
4.4.1. Instruments market estimates and forecasts 2021 - 2033 (USD Million)
4.4.2. Instruments, Type
4.4.3. Bench Top
4.4.3.1. Benchtop instruments market estimates and forecasts 2021 - 2033 (USD Million)
4.4.4. Portable
4.4.4.1. Portable instruments market estimates and forecasts 2021 - 2033 (USD Million)
4.4.5. Instruments, Brand
4.4.6. I-STAT
4.4.6.1. I-STAT market estimates and forecasts 2021 - 2033 (USD Million)
4.4.7. epoc
4.4.7.1. epoc market estimates and forecasts 2021 - 2033 (USD Million)
4.4.8. GEM Premier (3500& 5000)
4.4.8.1. GEM Premier (3500& 5000) market estimates and forecasts 2021 - 2033 (USD Million)
4.4.9. ABL Flex (90 and 800)
4.4.9.1. ABL Flex (90 and 800) market estimates and forecasts 2021 - 2033 (USD Million)
4.4.10. Cobas
4.4.10.1. Cobas market estimates and forecasts 2021 - 2033 (USD Million)
4.4.11. Portable RAPID Series
4.4.11.1. RAPID series market estimates and forecasts 2021 - 2033 (USD Million)
4.4.12. Others
4.4.12.1. Others market estimates and forecasts 2021 - 2033 (USD Million)
4.5. Consumables
4.5.1. Consumables market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 5. Blood Gas and Electrolyte Analyzer Market: End Use Estimates & Trend Analysis
5.1. Global Blood Gas and Electrolyte Analyzer Market: End Use Dashboard
5.2. Global Blood Gas and Electrolyte Analyzer Market: End Use Movement Analysis
5.3. Global Blood Gas and Electrolyte Analyzer Market by End Use, Revenue
5.4. Clinical Laboratory
5.4.1. Clinical laboratory market estimates and forecasts 2021 - 2033 (USD Million)
5.5. Point-of-care
5.5.1. Point-of-care market estimates and forecasts 2021 - 2033 (USD Million)
5.6. Diagnostic Centers
5.6.1. Diagnostic centers market estimates and forecasts 2021 - 2033 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 6. Blood Gas and Electrolyte Analyzer Market: Regional Estimates & Trend Analysis by Product and End Use
6.1. Regional Dashboard
6.2. Market Size & Forecast Trend Analysis, 2021 - 2033
6.2.1. Country-level analysis framework
6.2.1.1. Key country dynamics
6.2.1.2. Regulatory framework/reimbursement structure
6.2.1.3. Competitive scenario
6.2.1.4. Market estimates and forecasts 2021 - 2033 (USD Million)
6.3. North America
6.3.1. U.S.
6.3.2. Canada
6.4. Europe
6.4.1. UK
6.4.2. Germany
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.4.6. Norway
6.4.7. Sweden
6.4.8. Denmark
6.5. Asia Pacific
6.5.1. Japan
6.5.2. China
6.5.3. India
6.5.4. Australia
6.5.5. South Korea
6.5.6. Singapore
6.5.7. Malaysia
6.5.8. Indonesia
6.5.9. Thailand
6.5.10. Vietnam
6.5.11. Philippines
6.6. Latin America
6.6.1. Brazil
6.6.2. Mexico
6.6.3. Argentina
6.7. MEA
6.7.1. South Africa
6.7.2. Saudi Arabia
6.7.3. UAE
6.7.4. Kuwait
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Company profile framework
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Abbott
7.3.6. Meizhou Cornley High-Tech Co., Ltd.
7.3.7. Radiometer Medical ApS
7.3.8. EDAN Instruments, Inc.
7.3.9. Erba Mannheim
7.3.10. F. Hoffmann-La Roche Ltd
7.3.11. Fortress Diagnostics
7.3.12. Werfen
7.3.13. LifeHealth
7.3.14. Medica Corporation
7.3.15. OPTI Medical Systems, Inc.
7.3.16. Sensa Core
7.3.17. Siemens Healthineers AG
List of Tables [76]
List of Figures [58]
Companies Featured
- Abbott Laboratories Meizhou Cornley High-Tech Co., Ltd. Radiometer Medical ApS EDAN Instruments, Inc. Erba Mannheim F. Hoffmann-La Roche Ltd Fortress Diagnostics Werfen, S.A. LifeHealth Medica Corporation OPTI Medical Systems, Inc. Sensa Core Siemens Healthineers AG
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment